Browse studies

Find your next paid study

3,232 recruiting studies matching your filters

Effectiveness of Metabolic Modulation in Treating Post-vaccination Syndrome: A Prospective Study

The goal of this clinical trial is to evaluate whether metabolic modulation with a combined nutraceutical product can improve symptoms and metabolic health in …

Vaccine Adverse ReactionPost Acute Covid-19 Vaccination Syndrome

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Independent Medical AllianceNCT06967428

Phase 2

A Phase 2 Study of Epcoritamab-R-GemOx With Consolidative ASCT and Additional Epcoritamab in Relapsed/Refractory Transplant-Eligible DLBCL

This phase II trial tests how well epcoritamab in combination with rituximab, gemcitabine and oxaliplatin (R-GemOx) works as treatment given after the cancer h…

Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedRecurrent High Grade B-Cell Lymphoma, Not Otherwise SpecifiedRecurrent Primary Mediastinal Large B-Cell Lymphoma+5 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Phase 2

Strategic ENdocrine and Targeted Radiation therapY

The goal of this clinical trial is to study definitive external beam radiation therapy together with drugs called androgen deprivation therapy (ADT) in patient…

Prostate Adenocarcinoma

Estimated

~$75 – $2,000

Actual pay is set by the research site.

University of California, San DiegoNCT07364071

Phase 1

A Phase 1/2 Open Label, Dose Escalation and Expansion Study of MDNA11, IL-2 Superkine, Administered Alone or in Combination With Immune Checkpoint Inhibitor in Patients With Advanced Solid Tumors

This is a Phase 1/2, multi-center, open-label, dose-escalation and expansion study to evaluate safety and tolerability, PK, pharmacodynamic, and early signal o…

Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more

Estimated

Observational

Piloting an Early Intervention Program for Infants With Rare Neurogenetic Disorders

The objective is to develop and test, through an iterative process, an intervention to address and support the development of infants with a confirmed diagnosi…

Fragile X SyndromeAngelman SyndromePrader-Willi Syndrome+11 more

Estimated

~$10 – $1,125

Actual pay is set by the research site.

RTI InternationalNCT03836300

Phase 1

FIERCe: FOLR1 Immune Effector Cell Therapy Against Advanced Osteosarcoma

This phase I trial tests the safety, side effects, and best dose of FH-FOLR1 ST chimeric antigen receptor (CAR) T cells and how well they work in treating pati…

Advanced OsteosarcomaRecurrent OsteosarcomaRefractory Osteosarcoma

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Fred Hutchinson Cancer CenterNCT07227571

Observational

Outcomes With Multi Parametric MRI (mpMRI) Compared to Diagnostic Transurethral Resection of Bladder Tumor (TURBT) in Patients With Suspected Muscle-Invasive Bladder Cancer - a Pilot Study

This is a pilot, single arm, prospective study that aims to validate the accuracy of the VI-RADS score obtained via multi-parametric magnetic resonance imaging…

Urothelial Bladder CancerMuscle-Invasive Bladder Cancer

Estimated

~$10 – $750

Actual pay is set by the research site.

University of California, IrvineNCT06335667

Observational

Neurostimulation Enhanced Cognitive Restructuring for Transdiagnostic Emotional Dysregulation: A Component Analysis

The primary goal of this clinical trial is to evaluate the unique neural and behavioral effects of a one-session training combining emotion regulation skills t…

Emotion RegulationMood DisordersStress Disorder+12 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Duke UniversityNCT05712057

Molecular and Immunohistochemical Profiling of Tumor From Patients With Parathyroid Tumors for Evaluation of Targeted Agents

This trial studies molecular and immunohistochemical profiling of tumors in patients with parathyroid tumors. Studying molecular and immunohistochemical profil…

Parathyroid Gland AdenomaParathyroid Gland Atypical AdenomaParathyroid Gland Carcinoma+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT03039439

Phase 1

Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Patients With Solid Tumors

This is a pilot clinical trial determining the effect of a Methionine-reduced diet on serum levels in subjects with solid tumors. These are subjects who will r…

AdenocarcinomaBasal Cell CarcinomaSquamous Cell Carcinoma+12 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

University of California, IrvineNCT07628634

Phase 2

A Master Protocol of an Open-Label, Multi-Drug, Multi-Center, Phase II Platform Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma (GEMINI-PeriOp GC)

GEMINI-PeriOp GC study will assess the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor activity of novel agents or novel combinations as…

Gastroesophageal Adenocarcinoma

Estimated

~$75 – $3,000

Actual pay is set by the research site.

AstraZenecaNCT07069712

Phase 1

Phase I/II Study Evaluating the Safety and Tolerability of Locally Administered Anti-CD40 Agonist Antibody (2141-V11) in Subjects With Bladder Cancer

The purpose of this study is to test the safety of the study drug 2141-V11 in people whose NMIBC did not respond to standard treatment, and who will not have t…

Non-muscle Invasive Bladder Cancer

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Memorial Sloan Kettering Cancer CenterNCT05126472